USD 0.0
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 31.24 Million USD | -40.03% |
2022 | 52.09 Million USD | -55.15% |
2021 | 116.16 Million USD | -29.97% |
2020 | 165.87 Million USD | 73.3% |
2019 | 95.71 Million USD | 39.24% |
2018 | 68.74 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q1 | 46.23 Million USD | -11.25% |
2023 FY | 31.24 Million USD | -40.03% |
2023 Q2 | 42.83 Million USD | -7.36% |
2023 Q3 | 37.77 Million USD | -11.8% |
2023 Q4 | 31.24 Million USD | -17.3% |
2022 FY | 52.09 Million USD | -55.15% |
2022 Q4 | 52.09 Million USD | -36.01% |
2022 Q3 | 81.41 Million USD | -22.8% |
2022 Q2 | 105.46 Million USD | -17.1% |
2022 Q1 | 127.21 Million USD | 9.52% |
2021 Q2 | 149.77 Million USD | -5.62% |
2021 Q1 | 158.68 Million USD | -4.34% |
2021 FY | 116.16 Million USD | -29.97% |
2021 Q4 | 116.16 Million USD | -17.7% |
2021 Q3 | 141.13 Million USD | -5.77% |
2020 Q4 | 165.87 Million USD | 84.1% |
2020 FY | 165.87 Million USD | 73.3% |
2020 Q3 | 90.1 Million USD | 1.11% |
2020 Q2 | 89.11 Million USD | -13.95% |
2020 Q1 | 103.56 Million USD | 8.2% |
2019 Q4 | 95.71 Million USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | 95.71 Million USD | 39.24% |
2018 FY | 68.74 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Bright Green Corporation | 17.4 Million USD | -79.526% |
BioQuest Corp. | 5914.00 USD | -528188.806% |
Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 92.308% |
Guardion Health Sciences, Inc. | 11.91 Million USD | -162.146% |
GSRX Industries Inc. | - USD | -Infinity% |
High Sierra Technologies, Inc. | 101.5 Thousand USD | -30680.674% |
Instadose Pharma Corp. | - USD | -Infinity% |